1. Oral contraceptives and breast cancer

   Newsletter Article 12 February 2013 Pages: 2 - 2

2. Hepatotoxicity after halothane exposure

   Newsletter Article 12 February 2013 Pages: 2 - 3

3. Anxiolytics and antidepressants: psychomotor impairment

   Newsletter Article 12 February 2013 Pages: 3 - 3

4. Aciclovir

   Newsletter Article 12 February 2013 Pages: 4 - 4

5. Almitrine

   Newsletter Article 12 February 2013 Pages: 4 - 4

6. Amfepramone

   Newsletter Article 12 February 2013 Pages: 4 - 4

7. Aminoglycosides

   Newsletter Article 12 February 2013 Pages: 4 - 4

8. Amoxicillin + clavulanic acid

   Newsletter Article 12 February 2013 Pages: 4 - 4

9. Anaesthetics

   Newsletter Article 12 February 2013 Pages: 4 - 4

10. Antidepressants

    Newsletter Article 12 February 2013 Pages: 4 - 4

11. Antimalarials

    Newsletter Article 12 February 2013 Pages: 4 - 4

12. Atracurium besilate see Halothane/atracurium besilate

    Newsletter Article 12 February 2013 Pages: 4 - 4

13. Beclomethasone

    Newsletter Article 12 February 2013 Pages: 4 - 4

14. Benzodiazepine withdrawal

    Newsletter Article 12 February 2013 Pages: 5 - 5

15. Bupivacaine

    Newsletter Article 12 February 2013 Pages: 5 - 5

16. Buprenorphine

    Newsletter Article 12 February 2013 Pages: 5 - 5

17. Captopril/enalapril

    Newsletter Article 12 February 2013 Pages: 5 - 5

18. Chemotherapy/radiotherapy

    Newsletter Article 12 February 2013 Pages: 5 - 5

19. Chlorpropamide

    Newsletter Article 12 February 2013 Pages: 5 - 5

20. Cisplatin

    Newsletter Article 12 February 2013 Pages: 5 - 6

21. Clavulanic acid see Amoxicillin + clavulanic acid

    Newsletter Article 12 February 2013 Pages: 6 - 6

22. Cocaine

    Newsletter Article 12 February 2013 Pages: 6 - 6

23. Colchicine

    Newsletter Article 12 February 2013 Pages: 6 - 7

24. Cyclosporin

    Newsletter Article 12 February 2013 Pages: 7 - 7

25. Cytostatic antibiotics

    Newsletter Article 12 February 2013 Pages: 7 - 7

26. Diethylstilbestrol

    Newsletter Article 12 February 2013 Pages: 7 - 7

27. Dihydralazine

    Newsletter Article 12 February 2013 Pages: 7 - 7

28. Diltiazem

    Newsletter Article 12 February 2013 Pages: 7 - 7

29. Enalapril see Captopril/enalapril

    Newsletter Article 12 February 2013 Pages: 7 - 7

30. Encainide overdose

    Newsletter Article 12 February 2013 Pages: 7 - 7

31. Enflurane

    Newsletter Article 12 February 2013 Pages: 7 - 7

32. Epirubicin

    Newsletter Article 12 February 2013 Pages: 7 - 7

33. Ergotamine

    Newsletter Article 12 February 2013 Pages: 7 - 8

34. Ethylene glycol overdose

    Newsletter Article 12 February 2013 Pages: 8 - 8

35. Etretinate

    Newsletter Article 12 February 2013 Pages: 8 - 8

36. Gold

    Newsletter Article 12 February 2013 Pages: 8 - 8

37. Gonadorelin

    Newsletter Article 12 February 2013 Pages: 8 - 8

38. Halothane/atracurium besilate

    Newsletter Article 12 February 2013 Pages: 8 - 9

39. Hydrocortisone

    Newsletter Article 12 February 2013 Pages: 9 - 9

40. Ibuprofen

    Newsletter Article 12 February 2013 Pages: 9 - 9

41. Ibuprofen/indomethacin

    Newsletter Article 12 February 2013 Pages: 9 - 9

42. Indomethacin see ibuprofen/indomethacin

    Newsletter Article 12 February 2013 Pages: 9 - 9

43. Interferon

    Newsletter Article 12 February 2013 Pages: 9 - 9

44. Ketoprofen see Warfarin interaction

    Newsletter Article 12 February 2013 Pages: 9 - 9

45. Levonorgestrel withdrawal

    Newsletter Article 12 February 2013 Pages: 9 - 9

46. Lithium

    Newsletter Article 12 February 2013 Pages: 9 - 9

47. Lorazepam withdrawal

    Newsletter Article 12 February 2013 Pages: 9 - 9

48. Metoprolol

    Newsletter Article 12 February 2013 Pages: 9 - 10

49. Metronidazole/vancomycin

    Newsletter Article 12 February 2013 Pages: 10 - 10

50. Mitomycin

    Newsletter Article 12 February 2013 Pages: 10 - 10